• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

GeneDx Launches on Epic Aura, Expanding Access to Genomic Testing

by Fred Pennic 02/10/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
GeneDx Launches on Epic Aura, Expanding Access to Genomic Testing

What You Should Know: 

– GeneDx, a leader in delivering improved health outcomes through genomic insights, today announced its launch on Epic Aura, a specialty diagnostics suite within Epic’s electronic health records (EHR). 

– The integration allows health systems to directly order GeneDx’s genetic tests, including exome sequencing (ES), whole genome sequencing (WGS), and rapid whole genome sequencing (rWGS), within their EHR systems.

Enhanced Access to Genomic Testing

The integration with Epic Aura enables healthcare providers to seamlessly access GeneDx’s diagnostic services, streamlining the ordering process and accelerating the time to diagnosis for patients. By integrating with Epic Aura, health systems can now:

  • Order GeneDx tests directly within their EHR: This eliminates the need for manual data entry and reduces the risk of errors.
  • Receive results seamlessly: Results are automatically transmitted back to the EHR, ensuring timely access to patient information.
  • Improve efficiency and workflow: Streamline the diagnostic process and improve overall efficiency for clinicians.

Unmatched Experience in Genomic Testing

GeneDx has extensive experience in genomic testing, having sequenced over 750,000 exomes and genomes and collected millions of phenotypic data points. This vast dataset enables GeneDx to provide accurate and comprehensive diagnostic insights.

Future Expansion Plans

GeneDx plans to continue expanding its partnerships with health systems and integrating with other EHR platforms to further enhance access to genomic testing. The company is also committed to advancing its genomic technologies and expanding its offerings to address a wider range of genetic conditions.

“GeneDx is committed to providing patient-centered solutions and our use of Aura simplifies the process for healthcare providers to ensure the first step to treatment, an accurate and fast genetic diagnosis, is easily accessible at a patient’s bedside and in the exam room,” said Katherine Stueland, President and CEO of GeneDx. “There’s a reason 8 out of 10 genetics experts rely on GeneDx for exome and genome testing, we’ve empowered thousands of clinicians with genomic insights that have changed clinical care and led to better health outcomes for their patients.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |